Haoxiao Zheng
Overview
Explore the profile of Haoxiao Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wen W, Cao Y, Chen P, Li J, Li W, Huang G, et al.
Life Sci
. 2024 Oct;
358:123161.
PMID: 39433084
Background: Diabetic cardiomyopathy (DCM) is one of the leading causes of death in patients with diabetes mellitus (DM). This study aimed to identify a reliable method for establishing an animal...
2.
Zheng H, Li W, Huang G, Zhu H, Wen W, Liu X, et al.
Biochim Biophys Acta Mol Basis Dis
. 2023 Dec;
1870(2):166989.
PMID: 38101654
Objectives: Secreted frizzled-related protein 2 (SFRP2), a novel adipokine that used to be considered an inhibitor of the canonical Wnt pathway, may play a protective role in metabolic disorders. However,...
3.
Wu W, Ma W, Yuan S, Feng A, Li L, Zheng H, et al.
J Am Heart Assoc
. 2023 Nov;
12(23):e031440.
PMID: 38014686
Background: The role of nonalcoholic fatty liver disease (NAFLD) as a mediator in the association between various unhealthy lifestyles and major adverse cardiovascular events and all-cause death remains unclear. Methods...
4.
Wen W, Zheng H, Li W, Huang G, Chen P, Zhu X, et al.
Metabolism
. 2023 Jul;
147:155662.
PMID: 37517793
With the worldwide pandemic of metabolic diseases, such as obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD), cardiometabolic disease (CMD) has become a significant cause of death in humans. However,...
5.
Qiu M, Li J, Hao S, Zheng H, Zhang X, Zhu H, et al.
Front Endocrinol (Lausanne)
. 2023 May;
14:1167608.
PMID: 37152967
Background And Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of heart failure (HF) than those without NAFLD. However, the prognostic impact of NAFLD in HF...
6.
Sun L, Zheng H, Qiu M, Hao S, Liu X, Zhu X, et al.
Helicobacter
. 2023 Mar;
28(3):e12967.
PMID: 36974892
Background: Whether Helicobacter pylori (H. pylori) infection is associated with an increased risk of cardiovascular disease (CVD) remains controversial. This study aimed to investigate the association between H. pylori infection...
7.
Liu X, Zhu H, Zheng H, Sun L, Qiu M, Huang Y
J Evid Based Med
. 2022 Dec;
15(4):373-384.
PMID: 36510635
Aims: Statins had been used as a cornerstone in the primary and secondary prevention of cardiovascular disease. Widespread attention had been given to the risk of bleeding, especially intracranial hemorrhage...
8.
Zhu H, Zheng H, Liang X, Huang C, Sun L, Liu X, et al.
Front Physiol
. 2022 Jul;
13:936750.
PMID: 35846000
White coat hypertension (WCH) and masked hypertension (MH) can increase the risk of target organ damage. Home blood pressure monitoring is an important method for detecting WCH and MH. However,...
9.
Ma T, Huang X, Zheng H, Huang G, Li W, Liu X, et al.
Oxid Med Cell Longev
. 2021 Nov;
2021:9265016.
PMID: 34790288
Background: The mitochondrial dynamics and mitochondrial biogenesis are essential for maintaining the bioenergy function of mitochondria in diabetic cardiomyopathy (DCM). Previous studies have revealed that secreted frizzled-related protein 2 (SFRP2)...
10.
Zhu H, Zheng H, Xu T, Liu X, Liu X, Sun L, et al.
Vascul Pharmacol
. 2021 Nov;
142:106931.
PMID: 34763100
Objective: The associations between statins use and incidence or recurrence of venous thromboembolism (VTE) are controversial. We aimed to conduct a meta-analysis to reconcile the conflicting results. Methods: We searched...